Compare MIR & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIR | TWST |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | United States |
| Employees | 3281 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.2B |
| IPO Year | N/A | 2018 |
| Metric | MIR | TWST |
|---|---|---|
| Price | $16.74 | $93.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $27.25 | ★ $46.88 |
| AVG Volume (30 Days) | ★ 4.1M | 1.9M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $23.95 | $18.91 |
| Revenue Next Year | $7.32 | $15.07 |
| P/E Ratio | $195.00 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $15.57 | $23.30 |
| 52 Week High | $30.28 | $105.47 |
| Indicator | MIR | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 58.12 |
| Support Level | $15.62 | $87.57 |
| Resistance Level | $18.68 | $105.47 |
| Average True Range (ATR) | 0.61 | 6.41 |
| MACD | 0.00 | -0.96 |
| Stochastic Oscillator | 44.39 | 55.01 |
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.